Front-line DLBCL Therapies in Canada in 2026: Biology Matters. Canadian Hematology Today, Toronto, Canada, v. 5, n. 2, p. 47–58, 2026. DOI: 10.58931/cht.2026.5292. Disponível em: https://canadianhematologytoday.com/article/view/5-2-Liu_et_al. Acesso em: 24 sep. 2026.